77 related articles for article (PubMed ID: 7098179)
21. [Rheumatoid pleurisy with cholesterol pleural effusion. A single case. Literature review (author's transl)].
Riou R; Mauduit G; Touraine R
Poumon Coeur; 1980; 36(3):213-4. PubMed ID: 7433352
[TBL] [Abstract][Full Text] [Related]
22. [Transient appearance of double albumin in pleural effusion (author's transl)].
Senju O; Takagi Y; Yu H; Hosoya J; Gomi K; Ishii T
Rinsho Byori; 1978 Dec; 26(12):1055-8. PubMed ID: 745297
[No Abstract] [Full Text] [Related]
23. [Cytophotometry in cytology (report) (author's transl)].
Sandritter W
Verh Dtsch Ges Pathol; 1973; 57():42-52. PubMed ID: 4142259
[No Abstract] [Full Text] [Related]
24. DNA content of effusions.
Weich DJ; van Rensburg AJ
S Afr Med J; 1973 Sep; 47(38):1743-5. PubMed ID: 4745079
[No Abstract] [Full Text] [Related]
25. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
[TBL] [Abstract][Full Text] [Related]
26. [Glycoproteins of pleural effusions (author's transl)].
Dirat MF; Valdiguie P
Clin Chim Acta; 1977 Jun; 77(3):219-25. PubMed ID: 406107
[TBL] [Abstract][Full Text] [Related]
27. Quantitative light microscopy of atypical mesothelial cells and malignant cells in ascitic fluid.
van de Molengraft FJ; van 't Hof MA; Herman CJ; Vooijs PG
Anal Quant Cytol; 1982 Sep; 4(3):217-20. PubMed ID: 7149486
[TBL] [Abstract][Full Text] [Related]
28. Detection of c-Ha-ras oncogene expression in pleural and peritoneal smear effusions by in situ hybridization.
Athanassiadou PP; Veneti SZ; Kyrkou KA; Athanassiades PH
Cancer Detect Prev; 1993; 17(6):585-90. PubMed ID: 8275510
[TBL] [Abstract][Full Text] [Related]
29. Etiology and prognostic significance of massive pleural effusions.
Jiménez D; Díaz G; Gil D; Cicero A; Pérez-Rodríguez E; Sueiro A; Light RW
Respir Med; 2005 Sep; 99(9):1183-7. PubMed ID: 16085221
[TBL] [Abstract][Full Text] [Related]
30. Can we improve the cytologic examination of malignant pleural effusions using molecular analysis?
Brock MV; Hooker CM; Yung R; Guo M; Han Y; Ames SE; Chang D; Yang SC; Mason D; Sussman M; Baylin SB; Herman JG
Ann Thorac Surg; 2005 Oct; 80(4):1241-7. PubMed ID: 16181847
[TBL] [Abstract][Full Text] [Related]
31. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
32. Expression of intercellular adhesion molecule-1 (ICAM-1) by reactive mesothelial cells in pleural effusions.
Mutti L; Piacenza A; Valenti V; Castagneto B; Betta PG
Pathologica; 1993; 85(1100):725-8. PubMed ID: 7909596
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic value of cytophotometry in malignant pleural effusions.
Kuo SH; Luh KT; Wu MC; Lin CC; Yang SP
Taiwan Yi Xue Hui Za Zhi; 1986 Aug; 85(8):807-13. PubMed ID: 3467023
[No Abstract] [Full Text] [Related]
34. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
Bassarova AV; Nesland JM; Davidson B
Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
[TBL] [Abstract][Full Text] [Related]
35. [Differential diagnosis of pleural fluid (author's transl)].
He CQ
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Mar; 3(1):59-60. PubMed ID: 7428581
[No Abstract] [Full Text] [Related]
36. Role of immunoperoxidase staining in serous effusions.
Sarker AB; Hoshida Y; Nose S
Bangladesh Med Res Counc Bull; 1993 Aug; 19(2):33-8. PubMed ID: 8161332
[TBL] [Abstract][Full Text] [Related]
37. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
[TBL] [Abstract][Full Text] [Related]
38. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
39. [Explanation for mesothelial predominance in pleural effusion based on DNA cytophotometry and autoradiographic 3H-thymidine uptake].
Isoda K; Hamamoto Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Mar; 22(3):202-7. PubMed ID: 6748401
[No Abstract] [Full Text] [Related]
40. Evaluation of breast cancer metastases in pleural effusions by molecular biology techniques.
de Matos Granja N; Soares R; Rocha S; Paredes J; Longatto Filho A; Alves VA; Wiley E; Schmitt FC; Bedrossian C
Diagn Cytopathol; 2002 Oct; 27(4):210-3. PubMed ID: 12357497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
